· Singmed independently developed this single-dose capsule DPI platform. The platform has been applied in bioequivalence-oriented drug-device combination development programs with pharmaceutical partners. Its airflow path, capsule-piercing configuration and inspiratory resistance can be customized according to project requirements, supported by Singmed’s proprietary design and intellectual property portfolio.

· Inspiratory resistance range 0.03 to 0.06（kPa·s/L）